tiprankstipranks
Advertisement
Advertisement

Acadia Healthcare Refreshes Board With Finance Veteran Appointment

Story Highlights
  • Acadia Healthcare appointed seasoned finance leader Daniel Cancelmi to its board on March 12, 2026, adding deep healthcare financial expertise after his long tenure transforming Tenet Healthcare’s performance.
  • Director Wade D. Miquelon plans to retire at the 2026 annual meeting, as Acadia refreshes its board and reinforces strategic and financial oversight to support disciplined growth and shareholder value.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Acadia Healthcare Refreshes Board With Finance Veteran Appointment

Meet Samuel – Your Personal Investing Prophet

The latest update is out from Acadia Healthcare ( (ACHC) ).

On March 12, 2026, Acadia Healthcare announced the appointment of veteran healthcare finance executive Daniel Cancelmi to its board of directors, effective immediately, following a search led by the board’s nominating committee and an executive search firm. Cancelmi brings more than three decades of experience, including 11 years as CFO of Tenet Healthcare, where he oversaw a major portfolio transformation and balance sheet strengthening.

The company also said director Wade D. Miquelon will not stand for re-election at the 2026 annual meeting, marking a planned board transition as he retires after years of service guiding Acadia’s growth. The refreshed board composition, supported by financial advisers Goldman Sachs and J.P. Morgan and legal counsel Kirkland & Ellis, underscores Acadia’s effort to bolster financial and strategic oversight as it pursues disciplined growth and seeks to enhance shareholder value.

The most recent analyst rating on (ACHC) stock is a Hold with a $26.00 price target. To see the full list of analyst forecasts on Acadia Healthcare stock, see the ACHC Stock Forecast page.

Spark’s Take on ACHC Stock

According to Spark, TipRanks’ AI Analyst, ACHC is a Neutral.

The score is held down primarily by weakened recent financial quality (large TTM net loss and negative free cash flow) despite solid revenue growth and a balance sheet that is not distressed. Technicals are supportive but look overheated (very high RSI/Stochastic), and valuation is challenged by a negative P/E. Management’s 2026 outlook for positive free cash flow and solid adjusted profitability provides a partial offset, though key headwinds (PLGL, NY Medicaid, start-up losses, legal/regulatory uncertainty) remain.

To see Spark’s full report on ACHC stock, click here.

More about Acadia Healthcare

Acadia Healthcare Company, Inc. is a leading U.S. provider of behavioral healthcare services, operating 277 facilities with more than 12,500 beds across 40 states and Puerto Rico as of December 31, 2025. The company delivers inpatient psychiatric, specialty treatment, residential and outpatient behavioral health services through a network employing about 25,000 staff and treating over 84,000 patients daily.

As a stand-alone behavioral healthcare operator, Acadia focuses on expanding access to evidence-based mental health and recovery care while improving clinical outcomes and operational efficiency across its national footprint. Its business is conducted through a holding-company structure, with subsidiaries owning and operating its hospitals, centers, clinics and treatment facilities in the U.S. and Puerto Rico.

Average Trading Volume: 3,667,005

Technical Sentiment Signal: Hold

Current Market Cap: $2.2B

See more insights into ACHC stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1